Katie Ditmore Sinaikin

Katie Ditmore Sinaikin is a highly experienced professional in the field of analytics and insights, holding various senior director roles throughout a distinguished career. At Revolution Medicines, Katie serves as Senior Director of Analytics and Insights, while previously at IGM Biosciences, Inc., the role was Senior Director of New Product Planning. Katie's expertise in oncology is highlighted through a tenure at Gilead Sciences as Senior Director of Oncology Global Analytics and Insights. Additionally, at Halozyme Therapeutics, Inc., Katie contributed as Director of Commercial Analytics, Market Planning, & Competitive Intelligence, and at Counsyl held the position of Senior Director of Market Intelligence.